Thursday, April 14, 2005

Tungsten E2 in clinical trial

palmOne announced that invivodata, an industry leader in electronic patient reported outcome (PRO) solutions for clinical research, has plans to <A HREF="http://ir.palmone.com/phoenix.zhtml?c=105423&p=irol-newsArticle&ID=694894&highlight">deploy between 5,000 and 7,000 Tungsten E2 handhelds</A> from palmOne for use in worldwide clinical trials during the next 90 days. As the demand for invivodata's unique electronic diary system, DiaryPRO continues to grow, the number of deployed devices could easily be four times that amount by the end of 2005.

News Timeline



From Our Sponsor